Antithrombin III in the diagnosis of infection in febrile neutropenic patients.

AUTOR(ES)

Kibbler, C C

RESUMO

Antithrombin III levels in plasma were measured in 29 febrile neutropenic patients (31 episodes). They were lowest on day 2 in 62.5% of febrile patients and then increased or were normal in 81.3%. Low levels were present on day 2 in only 28.6% of patients with gram-negative infections, as compared with 33% of patients with doubtful infections.

Documentos Relacionados

• Steady-state pharmacokinetics of imipenem in febrile neutropenic cancer patients.
• Gentamicin pharmacokinetics, nephrotoxicity, and prediction of mortality in febrile neutropenic patients.
• PCR-ELISA for the early diagnosis of invasive pulmonary aspergillus infection in neutropenic patients.
• Preventing infection in neutropenic cancer patients.
• Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients.